References
- Zhang K, Letham D S, John P C. Cytokinin controls the cell cycle at mitosis by stimulating the tyrosine dephosphorylation and activation of p34cdc2-like H1histone kinase. Planta 1996; 200: 2–12.
- Rattan S I S, Clark B F C. Kinetin delays the onset of aging characteristics in human fibroblasts. Biochem Biophys Res Commun 1994; 201: 665–72.
- Sharma S P, Kaur P, Rattan S I S. Plant growth hormone kinetin delays aging, prolongs the lifespan, and slows down development of the fruitfly Zaprionus paravittiger. Biochem Biophys Res Commun 1995; 216: 1067–71.
- Goldstein S, Czapski G. SOD-like activity studies of cytokinin- copper (II) complexes. Free Radic Biol Med 1991; 12/13 Ptl: 173–7.
- Leshem Y Y. Plant senescence processes and free radicals. Free Radic Biol Med 1988; 5: 39–49.
- Sheu J R, Chao S H, Yen M H, Huang T F. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice. Thromb Haemost 1994; 72: 617–21.
- Hass W K, Easton J D, Adams H P, Pryse-Philips W, Molony B A, Anderson S, Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New Engl JMed 1989; 321: 501–7.
- Huang T F, Sheu J R, Teng C M. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem J 1991; 277: 351–7.
- Born G V R, Cross M J. The aggregation of blood platelets. J Physiol 1963; 168: 178–95.
- Sheu J R, Teng C M, Huang T F. Triflavin, an RGD- containing antiplatelet peptide, binds to GP IIIa of ADP- stimulated platelets. Biochem Biophys Res Commun 1992; 189: 1236–42.
- Sheu J R, Lin C H, Peng C H, Huang T F.Triflavin, an Arg- Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix protein via binding to multiple integrin receptors expressed on human hepatoma cells. Proc Soc Exp Biol Med 1996; 213: 71–9.
- Grynkiewicz G, Poenie M, Tsien R Y. A new generation of Ca2þ induces with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–50.
- Huang T F, Sheu J R, Teng C M. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavo- viridis snake venom. Thromb Haemost 1991; 66: 489–93.
- Karniguian A, Legrand Y J, Caen J P. Prostaglandins: specific inhibition of platelet adhesion to collagen and relationship with cyclic AMP level. Prostaglandins 1982; 23: 437–57.
- Touyz R M, Schiffrin E L. Effect of angiotensin II and endothelin-1on platelet aggregation and cytosolic pH and free Ca2þ concentrations in essential hypertension. Hypertension 1993; 22: 853–62.
- Horne W C, Norman N E, Schwartz D B, Simons E R. Changes in cytoplasmic pH and in membrane potential in thrombin-stimulated human platelets. Eur JBiochem 1981; 120: 295–302.
- Sheu J R, Lee C R, Lin C H, Hsiao G, Ko W C, Chen Y C, Yen M H. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb Haemost 2000; 83: 777–84.
- Broekman M J, Ward J W, Marcus A J. Phosphol- ipid metabolism in stimulated human platelet changes in phosphatidylinositol, phosphatidic acid, and lysophospholi- pids. J Clin Invest 1980; 66: 275–83.
- Kirk C J, Creba J A, Downes C P, Michell R H. Hormone- stimulated metabolism of inositol lipids and its relationship to hepatic receptor function. Biochem Soc Trans 1981; 9: 377–9.
- Olsen A, Siboska G E, Clark B F C, Rattan S I S. N6-Furfuryladenine, kinetin, protects against fenton reaction- mediated oxidative damage to DN A. Biochem Biophys Res Commun 1999; 265: 499–502.
- Rattan S I S, Clark B F C. Kinetin delays the onset of aging characteristics in human fibroblasts. Biochem Biophys Res Commun 1994; 201: 665–72.
- Charo I F, Feinman R D, Detwiler T C. Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochem Biophys Res Commun 1976; 72: 1462–7.
- Sheu J R, Hung W C, Wu C H, Ma M C, Kan Y C, Lin C H, Lin M S, Luk H N, Yen M H. Reduction in lipopolysacchar- ide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation 1999; 99: 3056–62.
- Berridge M J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J 1983; 212: 249–58.
- Hornby E J. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production. Biochem Pharmacol 1982; 31: 1158–60.
- McKean M L, Smith J B, Silver M J. Formation of lysophosphatidylcholine by human platelets in response to thrombin. J Biol Chem 1981; 256: 1522–4.
- Zavoico G B, Feinstein M B. Cytoplasmic Ca2þ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. Biochem Biophys Res Commun 1984; 120: 579–85.
- Chen S Y, Yu B J, Liang Y Q, Lin W D. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus. Chin Med J 1990; 103: 312–8.
- Sweatt J D, Johnson S L, Cargoe E J, Limbird L E. Inhibitor of Naþ/Hþ exchange block stimulus-provoked arachidonic acid release in human platelets. J Biol Chem 1985; 260: 12910–9.
- Kimura M, Lasker N, Aviv A. Cyclic nucleotides attenuate thrombin-evoked alterations in parameters of platelet Na/H antiport. The role of cytosolic Caþ2. J Clin Invest 1992; 89: 1121–7.
- Nieuwland R, Van Willigen G, Akkerman J W. Different pathways for control of Naþ/Hþ exchange via activation of the thrombin receptor. Biochem J 1994; 297: 47–52.
- Felder C C, Campbell T, Albrecht F, Jose P A. Dopamine inhibits Naþ–Hþ exchanger activity in renal BBMW by stimulation of adenylate cyclase. Am J Physiol 1990; 259: F297–303.
- Reid I R, Civitelli R, Avioli L V, Hruska K A. Parathyroid hormone depresses cytosolic pH and DNA synthesis in osteoblast-like cells. Am J Physiol 1988; 255: E9–15.